SCHEMBL7991568

SCHEMBL7991568

Nc1cccc(-c2nc(=O)c3c(ncn3Cc3cccc(Cl)c3)[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
GLA P06280 1/20 0.45
HTT P42858 1/20 0.45
UBE2N P61088 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ACP1 P24666 2/20 0.41
PARN O95453 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
YTHDC1 Q96MU7 2/20 0.41
MAPK1 P28482 1/20 0.41
FSCN1 Q16658 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CB P42338 1/20 0.39
CXCR2 P25025 1/20 0.39
PNP P00491 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973628 0.94 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7984663 0.92 CNOT7 (0.49) SMN1; SMN2PARNCNOT7PNPADORA2A
SCHEMBL7988669 0.91 PARN (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
Hydrochloric Acid SCHEMBL7987663 0.91 CNOT7 (0.48) SMN1; SMN2PARNCNOT7PNPADORA2A
SCHEMBL7974015 0.89 PARN (0.49) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7987312 0.89 GRIN1 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991647 0.89 SMN1; SMN2 (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991561 0.88 HPGD (0.43) SMN1; SMN2HTTACP1PARNCNOT7
SCHEMBL7985302 0.88 ROCK2 (0.41) ACP1PARNCNOT7MKNK1MKNK2
SCHEMBL7985362 0.87 GRIN1 (0.45) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed